2007

2007

| Saturday | Sunday | top

2160

ARHP

2249

Angiogenesis, Cell-Cell Adhesion Migration and Vascular Biology in Arthritis and Inflammation

2189

Animal Models of Rheumatoid Arthritis: Pathogenesis and Novel Therapeutic Targets

2191

Antiphospholipid Syndrome: Mechanisms of Vascular Pathology

2149

B-Cell Biology and Targets in Autoimmune Disease

2188

Biologic Therapies and RA Comorbidity

2221

Biologic Therapies in RA: Clinical Aspects

2251

Biologics in Pediatric Rheumatology: Clinical Trial Results

2219

Building Resilience: Kids and Joints

2192

Clinical Osteoporosis and Metabolic Bone Disease I

2244

Considerations in Arthritis Self-Help Programs

2164

Cytokines, Mediators and Gene Regulation I

2173

Cytokines, Mediators and Gene Regulation II

2228

Discovery 2007: Advances in the Management of Arthritis and Osteoporosis

2215

Discovery 2007: Pathogenesis and Treatment of Inflammatory Arthritis

2222

Drug Effectiveness in Rheumatology

2206

Drug Safety in Rheumatology

2208

Eclectic Rheumatology

2218

Education

2250

Education

2224

Emotional Well-being

2197

Epidemiology and Health Services Research I

2162

Epidemiology and Health Services Research II

2144

Epidemiology and Health Services Research: Comorbidities and Rheumatic Disease

2235

Fibromyalgia Perspectives

2212

Fibromyalgia: Etiology and Treatment

2193

Fibromyalgia: Etiology and Treatment I

2229

Genetics, Genomics and Proteomics I

2211

Genetics, Genomics and Proteomics II

2151

IL-17 and Related Cytokines in Rheumatic Disease

2209

Imaging of Rheumatic Diseases

2169

Improving Quality of Care by Design, Redesign and Innovation

2134

Improving Quality of Care by Design, Redesign, and Innovation

2254

Infection - Related Rheumatic Disease

2186

Late-Breaking Posters

2163

Miscellaneous Rheumatic and Inflammatory Diseases I

2232

New Methods for the Study of Drug Safety and Effectiveness in Rheumatology

2148

Osteoarthritis: Clinical Aspects I

2226

Pathogenesis of Sjogren's Syndrome

2143

Pediatric Rheumatology: Clinical and Therapeutic Aspects I

2182

Pediatric Rheumatology: Clinical and Therapeutic Aspects II

2201

Pharmaco-Economics of Treatments for Rheumatic Diseases

2241

Physical Activity in Musculoskeletal Disorders

2170

RA Animal Models: Novel Experimental Therapies

2181

RA New Treatments Clinical Trials I

2207

RA New and Established Therapies: Efficacy and Safety I

2141

RA New and Established Therapies: Efficacy and Safety II

2253

RA Pathogenesis: Genetics and the Environment

2185

RA Pathogenesis: Molecular Mechanisms

2174

RA: Clinical Aspects I

2158

RA: Clinical Aspects II

2178

RA: Human Etiology and Pathogenesis I

2135

RA: Human Etiology and Pathogenesis II

2255

REF Edmund L. Dubois, MD, Memorial Lectureship

2247

REF Marshall J. Schiff, MD, Memorial Lectureship

2156

SLE: Animal Models

2252

SLE: Animal Models

2142

SLE: Clinical Aspects and Treatment I

2138

SLE: Clinical Aspects and Treatment II

2243

SLE: Human Etiology and Pathogenesis

2165

SLE: Human Etiology and Pathogenesis I

2179

SLE: Novel Therapies

2199

Sjogren's Syndrome

2223

Spondylarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology

2205

Spondylarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology

2167

Spondylarthropathies and Psoriatic Arthritis: Treatment I

2157

Spondylarthropathies and Psoriatic Arthritis: Treatment II

2198

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Clinical Aspects and Therapeutics I

2159

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Pathogenesis, Animal Models and Genetics

2234

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Clinical Aspects and Therapeutics I

2171

Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's: Clinical Aspects and Therapeutics II

2220

T-Cell Modulation in Autoimmunity

2147

Uric Acid and Gout

2233

Vasculitis

2183

Vasculitis I

Saturday, November 10, 2007

| Saturday | Sunday | top

2187

ACR Business Meeting and Late-Breaking Abstracts

2194

ARHP

2214

Advances in Orthopedics

2152

Antiphospholipid Syndrome

2238

Arthritis in the Community

2137

B-cell Biology and Targets in Autoimmune Disease

2237

Biology and Pathology of Bone and Joint

2177

Biology and Pathology of Bone and Joint

2230

Cell-Cell Adhesion, Cell Trafficking and Angiogenesis

2204

Clinical Osteoporosis and Metabolic Bone Disease II

2213

Discovery 2007: Insights into Autoimmunity

2196

Epidemiology and Health Services Research III

2195

Epidemiology and Health Services Research: Primary, Secondary and Tertiary Prevention

2155

Fibromyalgia: Etiology and Treatment II

2139

Genetics, Genomics and Proteomics

2210

Improving Hand Function: From Pain to Evaluation to Splinting

2227

Infection Related Rheumatic Disease

2216

Innate Immunity Leading to Rheumatic Disease

2166

Innate Immunity and Rheumatic Disease

2140

Metabolic and Crystal Arthropathies

2176

Miscellaneous Rheumatic and Inflammatory Diseases II

2180

Muscle Biology, Myositis and Myopathies

2190

Muscle Biology, Myositis and Myopathies: New Insights Regarding Mechanism and Clinical Assessment

2200

Novel Molecular Mediators and Treatments

2153

Osteoarthritis: Clinical Aspects II

2150

Osteoporosis Treatment and Epidemiologic Updates

2236

Pathogenesis of Systemic Sclerosis: Key Pathways and Molecular Targets for Therapy

2239

Pediatric Rheumatology: Determinants and Markers of Disease

2172

Pediatric Rheumatology: From Genes to Cells

2136

Post-Surgical Rehabilitation and Low Back Pain

2175

RA Animal Models: Clues to Pathogenesis

2145

RA New Treatments Clinical Trials II

2154

RA Treatment: Novel Targets, Mechanisms of Action and Predictors of Response

2161

RA: Clinical Aspects III

2202

SLE: Clinical Aspects and Treatment III

2168

SLE: Human Etiology and Pathogenesis II

2242

SLE: Markers of Disease

2231

Spondylarthropathies and Psoriatic Arthritis: Treatment II

2146

T-Cells in Autoimmunity

2248

Therapeutic and Diagnostic Strategies in RA

2203

Vasculitis II

Sunday, November 11, 2007

| Saturday | Sunday | top

2245

Living the Good Life with Rheumatic Disease

2240

Pediatric Rheumatic Diseases: New Developments in Diagnosis, Treatment and Natural History

2225

Predictors of Disease Severity and RA Treatment Response

2246

SLE and Inflammatory Arthritis: Disease Activity and Outcomes Research

2184

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Clinical Aspects and Therapeutics II

2217

The Epidemiology of SLE